Logo image of AGIL

AGILETHOUGHT INC (AGIL) Stock Fundamental Analysis

NASDAQ:AGIL - Nasdaq - US00857F1003 - Common Stock - Currency: USD

0.197  +0.11 (+137.35%)

After market: 0.143 -0.05 (-27.41%)

Fundamental Rating

2

AGIL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. AGIL has a bad profitability rating. Also its financial health evaluation is rather negative. AGIL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AGIL had negative earnings in the past year.
AGIL had a positive operating cash flow in the past year.
AGIL had negative earnings in 4 of the past 5 years.
In multiple years AGIL reported negative operating cash flow during the last 5 years.
AGIL Yearly Net Income VS EBIT VS OCF VS FCFAGIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 10M -10M -20M

1.2 Ratios

AGIL has a Return On Assets of -36.78%. This is amonst the worse of the industry: AGIL underperforms 87.36% of its industry peers.
Looking at the Return On Equity, with a value of -234.27%, AGIL is doing worse than 78.16% of the companies in the same industry.
Industry RankSector Rank
ROA -36.78%
ROE -234.27%
ROIC N/A
ROA(3y)-10.12%
ROA(5y)N/A
ROE(3y)-63.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGIL Yearly ROA, ROE, ROICAGIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 33.04%, AGIL is in line with its industry, outperforming 47.13% of the companies in the same industry.
AGIL's Gross Margin has been stable in the last couple of years.
AGIL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
AGIL Yearly Profit, Operating, Gross MarginsAGIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

AGIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGIL has less shares outstanding
Compared to 1 year ago, AGIL has a worse debt to assets ratio.
AGIL Yearly Shares OutstandingAGIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
AGIL Yearly Total Debt VS Total AssetsAGIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.22, we must say that AGIL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.22, AGIL is not doing good in the industry: 85.06% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.01 indicates that AGIL is not too dependend on debt financing.
AGIL has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. AGIL outperforms 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC7.24%
AGIL Yearly LT Debt VS Equity VS FCFAGIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

AGIL has a Current Ratio of 0.31. This is a bad value and indicates that AGIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, AGIL is not doing good in the industry: 98.85% of the companies in the same industry are doing better.
A Quick Ratio of 0.31 indicates that AGIL may have some problems paying its short term obligations.
The Quick ratio of AGIL (0.31) is worse than 97.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
AGIL Yearly Current Assets VS Current LiabilitesAGIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M

3

3. Growth

3.1 Past

AGIL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.70%.
AGIL shows a decrease in Revenue. In the last year, the revenue decreased by -3.63%.
AGIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-119.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y0.59%
Revenue growth 5YN/A
Sales Q2Q%-16.98%

3.2 Future

Based on estimates for the next years, AGIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.72% on average per year.
The Revenue is expected to grow by 2.00% on average over the next years.
EPS Next Y-190.13%
EPS Next 2Y19.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.66%
Revenue Next 2Y2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGIL Yearly Revenue VS EstimatesAGIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AGIL Yearly EPS VS EstimatesAGIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

AGIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AGIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGIL Price Earnings VS Forward Price EarningsAGIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGIL Per share dataAGIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as AGIL's earnings are expected to grow with 19.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AGIL!.
Industry RankSector Rank
Dividend Yield N/A

AGILETHOUGHT INC

NASDAQ:AGIL (11/22/2023, 8:00:00 PM)

After market: 0.143 -0.05 (-27.41%)

0.197

+0.11 (+137.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)N/A N/A
Inst Owners0.4%
Inst Owner Change-53.59%
Ins Owners17.35%
Ins Owner Change0%
Market Cap10.32M
Analysts43.33
Price Target2.04 (935.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.86%
Min EPS beat(2)-380.2%
Max EPS beat(2)-357.52%
EPS beat(4)1
Avg EPS beat(4)-188.67%
Min EPS beat(4)-380.2%
Max EPS beat(4)160.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.87%
Min Revenue beat(2)-8.93%
Max Revenue beat(2)-4.82%
Revenue beat(4)1
Avg Revenue beat(4)-3.2%
Min Revenue beat(4)-8.93%
Max Revenue beat(4)1.04%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 8.75
P/B 0.35
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.02
OCFY11.43%
SpS3.18
BVpS0.56
TBVpS-1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.78%
ROE -234.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.04%
FCFM N/A
ROA(3y)-10.12%
ROA(5y)N/A
ROE(3y)-63.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.88%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -1.22
F-Score5
WACC7.24%
ROIC/WACCN/A
Cap/Depr(3y)16.84%
Cap/Depr(5y)20.07%
Cap/Sales(3y)0.71%
Cap/Sales(5y)0.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
EPS Next Y-190.13%
EPS Next 2Y19.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y0.59%
Revenue growth 5YN/A
Sales Q2Q%-16.98%
Revenue Next Year-6.66%
Revenue Next 2Y2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y95.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.7%
OCF growth 3YN/A
OCF growth 5YN/A